Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with advanced stage of cutaneous squamous cell carcinoma
- PMID: 34028804
- DOI: 10.1111/ajd.13619
Anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with advanced stage of cutaneous squamous cell carcinoma
References
-
- Day JA, Limaye V. Immune-mediated necrotising myopathy: a critical review of current concepts. Semin. Arthritis Rheum. 2019; 49: 420-9.
-
- Kadoya M, Hida A, Hashimoto Maeda M et al. Cancer association as a risk factor for anti-HMGCR antibody positive myopathy. Neurol. Neuroimmunol. Neuroinflamm. 2016; 3: e290.
-
- Allenbach Y, Keraen J, Bouvier AM et al. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain 2016; 139: 2131-5.
-
- Tsujikawa K, Hara K, Muro Y et al. HMGCR antibody-associated myopathy as a paraneoplastic manifestation of esophageal carcinoma. Neurology 2016; 87: 841-3.
-
- Mohassel P, Mammen AL. Anti-HMGCR myopathy. J. Neuromuscul. Dis. 2018; 5: 11-20.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical